Antiproliferative activity of side-chain truncated vitamin D analogs (PRI-1203 and PRI-1204) against human malignant melanoma cell lines.
Active Transport, Cell Nucleus
Antineoplastic Agents
/ chemistry
Calcitriol
/ analogs & derivatives
Cell Cycle Checkpoints
/ drug effects
Cell Line, Tumor
Cell Movement
/ drug effects
Cell Proliferation
/ drug effects
Enzyme Induction
Gene Expression Regulation, Neoplastic
Humans
Isomerism
Melanoma
/ drug therapy
Neoplasm Invasiveness
Receptors, Calcitriol
/ agonists
Skin Neoplasms
/ drug therapy
Structure-Activity Relationship
Vitamin D3 24-Hydroxylase
/ biosynthesis
Melanoma
PRI-1203
PRI-1204
Pregnacalciferol
Side-chain truncated vitamin D analogs
Vitamin D
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
15 Aug 2020
15 Aug 2020
Historique:
received:
14
01
2020
revised:
28
04
2020
accepted:
04
05
2020
pubmed:
24
5
2020
medline:
13
5
2021
entrez:
24
5
2020
Statut:
ppublish
Résumé
Vitamin D compounds are versatile molecules widely considered as promising agents in cancer prevention and treatment, including melanoma. Previously we investigated series of double point modified vitamin D
Identifiants
pubmed: 32445704
pii: S0014-2999(20)30262-4
doi: 10.1016/j.ejphar.2020.173170
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Receptors, Calcitriol
0
VDR protein, human
0
CYP24A1 protein, human
EC 1.14.15.16
Vitamin D3 24-Hydroxylase
EC 1.14.15.16
Calcitriol
FXC9231JVH
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
173170Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.